Magda Szubanski has provided fans with a heartfelt and surprisingly upbeat update as she battles stage four cancer.

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma in adults globally. 1 In the USA, DLBCL accounts for approximately one-quarter of all mature non-Hodgkin’s lymphomas, while ...